In an expansion of its strategic alliance with Salesforce, Deloitte has launched FastForward™ for Life Sciences, an agentic AI-infused customer relationship management (CRM) accelerator specifically designed to streamline front-office operations for mid-sized organizations. Arriving 70–90% pre-configured, the solution cuts traditional implementation timelines in half, allowing companies to go live in just four to six months rather than enduring multi-year software rollouts. Built on Deloitte’s IndustryAdvantage™ frame and Salesforce’s Agentforce infrastructure, the platform standardizes and modernizes critical commercial functions—including field team operations, healthcare professional (HCP) engagement, sampling, medical science liaison (MSL) workflows, and territory management—while embedding strict regional privacy and regulatory controls directly into the system architecture from day one. Addressing common bottlenecks in tech adoption, Pete Lyons, vice chair and U.S. life sciences leader at Deloitte Consulting LLP, noted: “We continually hear the same frustration from clients, mainly centering around the time they are devoting to updating their CRM systems. This offering provides tested, pre-configured workflows and setups across the commercial capability set that match how life sciences team’s work. Instead of debating field layouts for months, they’re launching pilots in weeks and spending time on what matters; getting therapies to patients faster.” Supporting global compliance, Nico Kleyn, Life Sciences leader at Deloitte EMEA, added: “The life sciences industry faces a challenge: accelerating digital innovation while navigating an increasingly complex global regulatory landscape across the US, Europe, Asia and other key markets. Deloitte’s FastForward™ for Life Sciences embeds compliance and privacy by design from day one, reducing rework and delays.” Further validating the alliance, Cahba Kingwood, Senior Vice President, Global Life Sciences Acceleration Hub at Salesforce, stated: “Salesforce sets the governance framework and quality bar that every certified partner utilizes with our accelerated life sciences program. That consistency is what makes implementations catch risk early, no matter who’s leading delivery. Deloitte has built deep experience following that structure, and FastForward™ reflects that investment.
Also Read: Dassault Systèmes Accelerates Life Sciences AI Strategy with $1.8 Billion Acquisition of ArisGlobal
It gives small and mid-sized life sciences organizations a collaborator with a proven, repeatable playbook, built on Salesforce’s standard for success. We look forward to working with Deloitte as they bring this program to our shared customers through active collaboration from the Global Life Sciences Acceleration Hub.” Concurrently highlighting the baseline platform capability, Joe Ferraro, SVP & GM, Agentforce Life Sciences at Salesforce, remarked: “Life sciences organizations are operating in an increasingly complex regulatory environment where even out-of-the-box solutions can require additional configuration to get right. Our industry-specific infrastructure provides the secure, agentic foundation that handles the heavy lifting by design, while Deloitte brings the blueprint that mid-sized organizations need to scale. Together, we’re removing the start-from-scratch barrier and giving these organizations an enterprise-grade operating system from day one.” In conclusion, this dual approach combines strong technology platforms with effective change management, allowing mid-sized life science companies to quickly scale up their commercial production capabilities and speed up drug delivery without breaking the bank.
